Literature DB >> 30156333

Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization.

Jiani Xie1, Linji Gong1, Shuang Zhu1, Yuan Yong1, Zhanjun Gu1,2, Yuliang Zhao1,2,3.   

Abstract

Nano-radiosensitization has been a hot concept for the past ten years, and the nanomaterial-mediated tumor radiosensitization method is mainly focused on increasing intracellular radiation deposition by high atomic number (high Z) nanomaterials, particularly gold (Au)-mediated radiation enhancement. Recently, various new nanomaterial-mediated radiosensitive approaches have been successively reported, such as catalyzing reactive oxygen species (ROS) generation, consuming intracellular reduced glutathione (GSH), overcoming tumor hypoxia, and various synergistic radiotherapy ways. These strategies may open a new avenue for enhancing the radiotherapeutic effect and avoiding its side effects. Nevertheless, reviews systematically summarizing these newly emerging methods and their radiosensitive mechanisms are still rare. Therefore, the general strategies of nanomaterial-mediated tumor radiosensitization are comprehensively summarized, particularly aiming at introducing the emerging radiosensitive methods. The strategies are divided into three general parts. First, methods on account of the intrinsic radiosensitive properties of nanoradiosensitizers for radiosensitization are highlighted. Then, newly developed synergistic strategies based on multifunctional nanomaterials for enhancing radiotherapy efficacy are emphasized. Third, nanomaterial-mediated radioprotection approaches for increasing the radiotherapeutic ratio are discussed. Importantly, the clinical translation of nanomaterial-mediated tumor radiosensitization is also covered. Finally, further challenges and outlooks in this field are discussed.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  clinical translation; nanomaterial-mediated radiosensitization; nanoradiosensitizers; radioprotection; synergistic radiotherapy

Mesh:

Substances:

Year:  2018        PMID: 30156333     DOI: 10.1002/adma.201802244

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  32 in total

1.  A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.

Authors:  Taokun Luo; Geoffrey T Nash; Xiaomin Jiang; Xuanyu Feng; Jianming Mao; Jianqiao Liu; Aditya Juloori; Alexander T Pearson; Wenbin Lin
Journal:  Adv Mater       Date:  2022-08-26       Impact factor: 32.086

Review 2.  Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Authors:  Madhusudhan Alle; Garima Sharma; Seung-Hwan Lee; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2022-07-02       Impact factor: 9.429

3.  Composition tunability of semiconductor radiosensitizers for low-dose X-ray induced photodynamic therapy.

Authors:  Lei Chen; Jinghui Zhang; Lihua Xu; Luchao Zhu; Jinpeng Jing; Yushuo Feng; Zongzhang Wang; Peifei Liu; Wenjing Sun; Xiangmei Liu; Yimin Li; Hongmin Chen
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

4.  Breaking photoswitch activation depth limit using ionising radiation stimuli adapted to clinical application.

Authors:  Alban Guesdon-Vennerie; Patrick Couvreur; Fatoumia Ali; Frédéric Pouzoulet; Christophe Roulin; Immaculada Martínez-Rovira; Guillaume Bernadat; François-Xavier Legrand; Claudie Bourgaux; Cyril Lucien Mazars; Sergio Marco; Sylvain Trépout; Simona Mura; Sébastien Mériaux; Guillaume Bort
Journal:  Nat Commun       Date:  2022-07-14       Impact factor: 17.694

Review 5.  Nanotechnology synergized immunoengineering for cancer.

Authors:  Deepak S Chauhan; Anupam Dhasmana; Partha Laskar; Rajendra Prasad; Nishant K Jain; Rohit Srivastava; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Eur J Pharm Biopharm       Date:  2021-03-24       Impact factor: 5.589

Review 6.  Smart H2S-Triggered/Therapeutic System (SHTS)-Based Nanomedicine.

Authors:  Weiyu Chen; Dalong Ni; Zachary T Rosenkrans; Tianye Cao; Weibo Cai
Journal:  Adv Sci (Weinh)       Date:  2019-10-14       Impact factor: 16.806

7.  Impact of the Spectral Composition of Kilovoltage X-rays on High-Z Nanoparticle-Assisted Dose Enhancement.

Authors:  Maria A Kolyvanova; Alexandr V Belousov; Grigorii A Krusanov; Alexandra K Isagulieva; Kirill V Morozov; Maria E Kartseva; Magomet H Salpagarov; Pavel V Krivoshapkin; Olga V Dement'eva; Victor M Rudoy; Vladimir N Morozov
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

8.  Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer.

Authors:  Dong Luo; Andrew Johnson; Xinning Wang; Hao Li; Bernadette O Erokwu; Sarah Springer; Jason Lou; Gopalakrishnan Ramamurthy; Chris A Flask; Clemens Burda; Thomas J Meade; James P Basilion
Journal:  Nano Lett       Date:  2020-08-31       Impact factor: 12.262

9.  Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

Authors:  Yuan Ding; Zhongquan Sun; Zongrui Tong; Sitong Zhang; Jie Min; Qianhui Xu; Liuzhi Zhou; Zhengwei Mao; Haibing Xia; Weilin Wang
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

Review 10.  Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy.

Authors:  Manal Ali Buabeid; El-Shaimaa A Arafa; Ghulam Murtaza
Journal:  J Immunol Res       Date:  2020-01-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.